Avastin (Genentech, Inc.)
Welcome to the PulseAid listing for the Avastin drug offered from Genentech, Inc.. This Vascular Endothelial Growth Factor Receptor Inhibitors [MoA],Vascular Endothelial Growth Factor-directed Antibody [EPC],Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | bevacizumab |
| SUBSTANCE NAME: | BEVACIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vascular Endothelial Growth Factor Receptor Inhibitors [MoA],Vascular Endothelial Growth Factor-directed Antibody [EPC],Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2004-02-26 |
| END MARKETING DATE: | 0000-00-00 |
Avastin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Avastin from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/4mL) |
| START MARKETING DATE: | 2004-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-060_5bad98ba-6c48-4686-b570-fbc86af9e398 |
| PRODUCT NDC: | 50242-060 |
| APPLICATION NUMBER: | BLA125085 |
Other BEVACIZUMAB Pharmaceutical Manufacturers / Labelers:
